Stefanie Sarantopulos, MD, PhD

Duke University School of Medicine

Financial Disclosure

NIH-funded Sarantopoulos’ lab work supports ongoing clinical trial (SYK inhibitor + JAK1/JAK2 inhibitor for steroid-refractory disease

Contractor

Rigel Pharmaceutical supplies SYK inhibitor, fostamatinib, and some support for research personnel

Researcher

Incyte supplies JAK1/2 inhibitor, ruxolitinib, and some support for research personnel

Researcher